T1	Premise 45 115	A patient with obesity (body mass index 38) is referred to your office
T2	Premise 117 340	In the clinical history the patient refers that he/she has been obese since the age of 17 (currently 36 years old), having been on multiple diets with weight loss ranging from 5 to 10 kg but has subsequently regained weight
T3	Premise 342 522	The patient is currently on a 1500 Kcal diet (self-administered and not restricted in fat) with a good follow-up of this diet, performing one hour of aerobic exercise 4 days a week
T4	Premise 524 583	She has lost 3 kg but needs an additional loss of 7 kg more
T5	Claim 694 702	Orlistat
T6	Claim 707 717	Topiramate
T7	Claim 722 733	Sibutramine
T8	Claim 738 749	Liraglutide
T9	Claim 754 763	Metformin
T10	Treatment 694 702	Orlistat
T11	Treatment 707 717	Topiramate
T12	Treatment 722 733	Sibutramine
T13	Treatment 738 749	Liraglutide
T14	Treatment 754 763	Metformin
T15	Claim 783 884	Orlistat acts by decreasing fat absorption; it is currently the only drug approved for use in obesity
T16	Treatment 783 791	Orlistat
R1	Support Ent1:T15 Ent2:T5	
R2	Attack Ent1:T15 Ent2:T6	
R3	Attack Ent1:T15 Ent2:T7	
R4	Attack Ent1:T15 Ent2:T8	
R5	Attack Ent1:T15 Ent2:T9	
